Drug profile · INN
tisotumab vedotin-tftv
TIVDAK
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tisotumab vedotin-tftv (TIVDAK) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN tisotumab vedotin-tftv
Brand TIVDAK
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is tisotumab vedotin-tftv?
tisotumab vedotin-tftv (TIVDAK) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tisotumab vedotin-tftv?
TIVDAK is a marketed brand name for tisotumab vedotin-tftv. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tisotumab vedotin-tftv?
tisotumab vedotin-tftv has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.